Inari Medical, Inc. (NARI)
Total Valuation
Inari Medical has a market cap or net worth of $2.80 billion. The enterprise value is $2.72 billion.
Market Cap | 2.80B |
Enterprise Value | 2.72B |
Important Dates
The next estimated earnings date is Wednesday, May 1, 2024, after market close.
Earnings Date | May 1, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Inari Medical has 57.96 million shares outstanding. The number of shares has increased by 7.44% in one year.
Shares Outstanding | 57.96M |
Shares Change (YoY) | +7.44% |
Shares Change (QoQ) | -11.94% |
Owned by Insiders (%) | 9.57% |
Owned by Institutions (%) | 91.44% |
Float | 52.41M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 5.67 |
Forward PS | 4.66 |
PB Ratio | 6.03 |
P/FCF Ratio | 94.24 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 179.04, with an EV/FCF ratio of 91.41.
EV / Earnings | n/a |
EV / Sales | 5.50 |
EV / EBITDA | 179.04 |
EV / EBIT | 611.71 |
EV / FCF | 91.41 |
Financial Position
The company has a current ratio of 3.09, with a Debt / Equity ratio of 0.07.
Current Ratio | 3.09 |
Quick Ratio | 2.44 |
Debt / Equity | 0.07 |
Debt / EBITDA | 2.11 |
Debt / FCF | 1.08 |
Interest Coverage | 22.66 |
Financial Efficiency
Return on equity (ROE) is -0.40%.
Return on Equity (ROE) | -0.40% |
Return on Assets (ROA) | -0.30% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $379,717 |
Profits Per Employee | -$1,258 |
Employee Count | 1,300 |
Asset Turnover | 0.88 |
Inventory Turnover | 1.57 |
Taxes
In the past 12 months, Inari Medical has paid $5.88 million in taxes.
Income Tax | 5.88M |
Effective Tax Rate | 138.53% |
Stock Price Statistics
The stock price has decreased by -23.17% in the last 52 weeks. The beta is 0.84, so Inari Medical's price volatility has been lower than the market average.
Beta (1Y) | 0.84 |
52-Week Price Change | -23.17% |
50-Day Moving Average | 51.67 |
200-Day Moving Average | 58.85 |
Relative Strength Index (RSI) | 52.44 |
Average Volume (30 Days) | 1,003,919 |
Short Selling Information
The latest short interest is 3.58 million, so 6.18% of the outstanding shares have been sold short.
Short Interest | 3.58M |
Short Previous Month | 5.05M |
Short % of Shares Out | 6.18% |
Short % of Float | 6.84% |
Short Ratio (days to cover) | 2.78 |
Income Statement
In the last 12 months, Inari Medical had revenue of $493.63 million and -$1.64 million in losses. Loss per share was -$0.03.
Revenue | 493.63M |
Gross Profit | 434.56M |
Operating Income | -14.03M |
Pretax Income | 4.25M |
Net Income | -1.64M |
EBITDA | 15.18M |
EBIT | 4.44M |
Loss Per Share | -$0.03 |
Balance Sheet
The company has $116.06 million in cash and $32.05 million in debt, giving a net cash position of $84.02 million or $1.45 per share.
Cash & Cash Equivalents | 116.06M |
Total Debt | 32.05M |
Net Cash | 84.02M |
Net Cash Per Share | $1.45 |
Equity / Book Value | 464.91M |
Book Value Per Share | 8.02 |
Working Capital | 159.22M |
Cash Flow
In the last 12 months, operating cash flow was $35.93 million and capital expenditures -$6.20 million, giving a free cash flow of $29.73 million.
Operating Cash Flow | 35.93M |
Capital Expenditures | -6.20M |
Free Cash Flow | 29.73M |
FCF Per Share | $0.52 |
Margins
Gross margin is 88.03%, with operating and profit margins of -2.84% and -0.33%.
Gross Margin | 88.03% |
Operating Margin | -2.84% |
Pretax Margin | 0.86% |
Profit Margin | -0.33% |
EBITDA Margin | 3.07% |
EBIT Margin | 0.90% |
FCF Margin | 6.02% |
Dividends & Yields
Inari Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -7.44% |
Shareholder Yield | -7.44% |
Earnings Yield | -0.06% |
FCF Yield | 1.06% |
Analyst Forecast
The average price target for Inari Medical is $69.33, which is 44.50% higher than the current price. The consensus rating is "Buy".
Price Target | $69.33 |
Price Target Difference | 44.50% |
Analyst Consensus | Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | 20.01% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Inari Medical has an Altman Z-Score of 8.97 and a Piotroski F-Score of 4.
Altman Z-Score | 8.97 |
Piotroski F-Score | 4 |